25 XP   0   0   10

Kangmei Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Kangmei together

PenkeI guess you are interested in Kangmei Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Kangmei Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Kangmei Pharmaceutical Co Ltd

I send you an email if I find something interesting about Kangmei Pharmaceutical Co Ltd.

Quick analysis of Kangmei (30 sec.)










What can you expect buying and holding a share of Kangmei? (30 sec.)

How much money do you get?

How much money do you get?
¥0.00
When do you have the money?
1 year
How often do you get paid?
92.3%

What is your share worth?

Current worth
¥0.49
Expected worth in 1 year
¥0.33
How sure are you?
61.5%

+ What do you gain per year?

Total Gains per Share
¥-0.16
Return On Investment
-7.4%

For what price can you sell your share?

Current Price per Share
¥2.17
Expected price per share
¥2.02 - ¥2.42
How sure are you?
50%

1. Valuation of Kangmei (5 min.)




Live pricePrice per Share (EOD)

¥2.17

Intrinsic Value Per Share

¥-1.99 - ¥0.24

Total Value Per Share

¥-1.50 - ¥0.73

2. Growth of Kangmei (5 min.)




Is Kangmei growing?

Current yearPrevious yearGrowGrow %
How rich?$945.8m$1.3b-$382.9m-40.1%

How much money is Kangmei making?

Current yearPrevious yearGrowGrow %
Making money-$67.5m$278.7m-$346.2m-513.0%
Net Profit Margin-34.0%185.9%--

How much money comes from the company's main activities?

3. Financial Health of Kangmei (5 min.)




What can you expect buying and holding a share of Kangmei? (5 min.)

Welcome investor! Kangmei's management wants to use your money to grow the business. In return you get a share of Kangmei.

What can you expect buying and holding a share of Kangmei?

First you should know what it really means to hold a share of Kangmei. And how you can make/lose money.

Speculation

The Price per Share of Kangmei is ¥2.17. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kangmei.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kangmei, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥0.49. Based on the TTM, the Book Value Change Per Share is ¥-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.37 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kangmei.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.000.0%0.000.0%0.020.9%0.00-0.1%0.000.1%
Usd Book Value Change Per Share0.000.0%-0.01-0.3%0.052.4%-0.01-0.6%0.00-0.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.010.3%
Usd Total Gains Per Share0.000.0%-0.01-0.3%0.052.4%-0.01-0.6%0.000.2%
Usd Price Per Share0.26-0.28-0.35-0.48-1.50-
Price to Earnings Ratio-291.04--144.88--48.41--61.90-15.33-
Price-to-Total Gains Ratio-1,072.96--506.09--195.31--11.60-124.94-
Price to Book Ratio3.77-4.09-3.60-1.67-6.93-
Price-to-Total Gains Ratio-1,072.96--506.09--195.31--11.60-124.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.300328
Number of shares3329
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share-0.01-0.01
Gains per Quarter (3329 shares)-18.61-40.77
Gains per Year (3329 shares)-74.43-163.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-74-8422-185-173
20-149-15844-371-336
30-223-23267-556-499
40-298-30689-741-662
50-372-380111-927-825
60-447-454133-1112-988
70-521-528156-1297-1151
80-596-602178-1483-1314
90-670-676200-1668-1477
100-745-750222-1853-1640

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%21.018.00.053.8%68.018.00.079.1%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%18.021.00.046.2%63.023.00.073.3%
Dividend per Share1.00.03.025.0%9.00.03.075.0%17.00.03.085.0%36.00.03.092.3%80.00.06.093.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%5.015.00.025.0%24.015.00.061.5%71.015.00.082.6%

Fundamentals of Kangmei

About Kangmei Pharmaceutical Co Ltd

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. It also offers chemical medicines and health food; and operates hospitals and pharmacies. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Shenzhen, China.

Fundamental data was last updated by Penke on 2024-03-26 18:11:08.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Kangmei Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kangmei earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1.9% means that ¥-0.02 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is -1.9%. The company is making a loss. -1
  • The TTM is -34.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1.9%TTM-34.0%+32.1%
TTM-34.0%YOY185.9%-219.9%
TTM-34.0%5Y-93.7%+59.7%
5Y-93.7%10Y-41.0%-52.7%
1.1.2. Return on Assets

Shows how efficient Kangmei is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.2% Return on Assets means that Kangmei generated ¥0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is -0.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -3.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.2%TTM-3.2%+3.1%
TTM-3.2%YOY12.5%-15.7%
TTM-3.2%5Y-2.4%-0.8%
5Y-2.4%10Y-0.4%-2.1%
1.1.3. Return on Equity

Shows how efficient Kangmei is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • -0.3% Return on Equity means Kangmei generated ¥0.00 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is -0.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.3%TTM-7.0%+6.7%
TTM-7.0%YOY20.1%-27.1%
TTM-7.0%5Y0.6%-7.6%
5Y0.6%10Y2.0%-1.4%

1.2. Operating Efficiency of Kangmei Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kangmei is operating .

  • Measures how much profit Kangmei makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-2.3%+2.3%
TTM-2.3%YOY382.7%-385.0%
TTM-2.3%5Y55.4%-57.6%
5Y55.4%10Y29.3%+26.0%
1.2.2. Operating Ratio

Measures how efficient Kangmei is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.93 means that the operating costs are ¥1.93 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is 1.926. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.023. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.926TTM2.023-0.096
TTM2.023YOY-1.960+3.983
TTM2.0235Y1.246+0.777
5Y1.24610Y1.024+0.222

1.3. Liquidity of Kangmei Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kangmei is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.36 means the company has ¥1.36 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is 1.363. The company is just able to pay all its short-term debts.
  • The TTM is 1.372. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.363TTM1.372-0.009
TTM1.372YOY1.628-0.256
TTM1.3725Y1.716-0.343
5Y1.71610Y0.997+0.719
1.3.2. Quick Ratio

Measures if Kangmei is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.36 means the company can pay off ¥0.36 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is 0.358. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.413. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.358TTM0.413-0.055
TTM0.413YOY0.498-0.086
TTM0.4135Y0.498-0.085
5Y0.49810Y0.374+0.124

1.4. Solvency of Kangmei Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kangmei assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kangmei to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.53 means that Kangmei assets are financed with 53.1% credit (debt) and the remaining percentage (100% - 53.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is 0.531. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.533. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.531TTM0.533-0.002
TTM0.533YOY0.388+0.144
TTM0.5335Y0.693-0.160
5Y0.69310Y0.590+0.103
1.4.2. Debt to Equity Ratio

Measures if Kangmei is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 113.7% means that company has ¥1.14 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The MRQ is 1.137. The company is able to pay all its debts with equity. +1
  • The TTM is 1.145. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.137TTM1.145-0.008
TTM1.145YOY0.639+0.506
TTM1.1455Y1.117+0.028
5Y1.11710Y1.037+0.080

2. Market Valuation of Kangmei Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Kangmei generates.

  • Above 15 is considered overpriced but always compare Kangmei to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -291.04 means the investor is paying ¥-291.04 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The EOD is -339.541. Based on the earnings, the company is expensive. -2
  • The MRQ is -291.035. Based on the earnings, the company is expensive. -2
  • The TTM is -144.881. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-339.541MRQ-291.035-48.506
MRQ-291.035TTM-144.881-146.155
TTM-144.881YOY-48.414-96.467
TTM-144.8815Y-61.899-82.982
5Y-61.89910Y15.335-77.234
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The EOD is -103.891. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -89.049. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 672.587. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-103.891MRQ-89.049-14.842
MRQ-89.049TTM672.587-761.636
TTM672.587YOY-2.645+675.232
TTM672.5875Y173.630+498.957
5Y173.63010Y115.688+57.941
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kangmei is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Kangmei Pharmaceutical Co Ltd:

  • The EOD is 4.402. Based on the equity, the company is fair priced.
  • The MRQ is 3.773. Based on the equity, the company is fair priced.
  • The TTM is 4.086. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD4.402MRQ3.773+0.629
MRQ3.773TTM4.086-0.313
TTM4.086YOY3.601+0.485
TTM4.0865Y1.667+2.419
5Y1.66710Y6.926-5.259
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Kangmei Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.002-0.040+2230%0.369-100%-0.101+5701%-0.009+402%
Book Value Per Share--0.4930.498-1%0.697-29%0.816-40%1.225-60%
Current Ratio--1.3631.372-1%1.628-16%1.716-21%0.997+37%
Debt To Asset Ratio--0.5310.5330%0.388+37%0.693-23%0.590-10%
Debt To Equity Ratio--1.1371.145-1%0.639+78%1.117+2%1.037+10%
Dividend Per Share---0.000-100%0.000-100%0.012-100%0.040-100%
Eps---0.002-0.004+180%0.145-101%-0.013+703%0.020-108%
Free Cash Flow Per Share---0.005-0.014+159%-0.006+10%-0.009+72%-0.011+116%
Free Cash Flow To Equity Per Share---0.005-0.015+178%0.042-113%-0.030+469%0.092-106%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--0.239--------
Intrinsic Value_10Y_min---1.993--------
Intrinsic Value_1Y_max---0.018--------
Intrinsic Value_1Y_min---0.072--------
Intrinsic Value_3Y_max---0.021--------
Intrinsic Value_3Y_min---0.328--------
Intrinsic Value_5Y_max--0.013--------
Intrinsic Value_5Y_min---0.705--------
Market Cap30084663347.200+14%25786854297.60028213036825.600-9%35006347904.000-26%48405807408.640-47%150074941808.903-83%
Net Profit Margin---0.019-0.340+1677%1.859-101%-0.937+4796%-0.410+2044%
Operating Margin----0.0230%3.827-100%0.554-100%0.293-100%
Operating Ratio--1.9262.023-5%-1.960+202%1.246+55%1.024+88%
Pb Ratio4.402+14%3.7734.086-8%3.601+5%1.667+126%6.926-46%
Pe Ratio-339.541-17%-291.035-144.881-50%-48.414-83%-61.899-79%15.335-1998%
Price Per Share2.170+14%1.8602.035-9%2.525-26%3.492-47%10.825-83%
Price To Free Cash Flow Ratio-103.891-17%-89.049672.587-113%-2.645-97%173.630-151%115.688-177%
Price To Total Gains Ratio-1251.791-17%-1072.964-506.089-53%-195.308-82%-11.601-99%124.944-959%
Quick Ratio--0.3580.413-13%0.498-28%0.498-28%0.374-4%
Return On Assets---0.002-0.032+2027%0.125-101%-0.024+1507%-0.004+135%
Return On Equity---0.003-0.070+2058%0.201-102%0.006-153%0.020-116%
Total Gains Per Share---0.002-0.040+2230%0.369-100%-0.088+5005%0.032-105%
Usd Book Value--945833416.478955133944.386-1%1338078654.568-29%1565091368.406-40%2350615939.307-60%
Usd Book Value Change Per Share--0.000-0.006+2230%0.051-100%-0.014+5701%-0.001+402%
Usd Book Value Per Share--0.0680.069-1%0.097-29%0.113-40%0.170-60%
Usd Dividend Per Share---0.000-100%0.000-100%0.002-100%0.006-100%
Usd Eps--0.000-0.001+180%0.020-101%-0.002+703%0.003-108%
Usd Free Cash Flow---10019461.400-25908759.778+159%-10992935.931+10%-17261165.162+72%-21597052.037+116%
Usd Free Cash Flow Per Share---0.001-0.002+159%-0.001+10%-0.001+72%-0.002+116%
Usd Free Cash Flow To Equity Per Share---0.001-0.002+178%0.006-113%-0.004+469%0.013-106%
Usd Market Cap4163717407.252+14%3568900634.7883904684296.663-9%4844878549.914-26%6699363745.356-47%20770371946.352-83%
Usd Price Per Share0.300+14%0.2570.282-9%0.349-26%0.483-47%1.498-83%
Usd Profit---3065691.897-67501587.565+2102%278762522.133-101%-200785069.308+6449%-51588003.478+1583%
Usd Revenue--160145311.537172739246.140-7%131074990.493+22%239530038.625-33%475501674.119-66%
Usd Total Gains Per Share--0.000-0.006+2230%0.051-100%-0.012+5005%0.004-105%
 EOD+5 -3MRQTTM+22 -12YOY+7 -285Y+18 -1710Y+14 -21

3.2. Fundamental Score

Let's check the fundamental score of Kangmei Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-339.541
Price to Book Ratio (EOD)Between0-14.402
Net Profit Margin (MRQ)Greater than0-0.019
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.358
Current Ratio (MRQ)Greater than11.363
Debt to Asset Ratio (MRQ)Less than10.531
Debt to Equity Ratio (MRQ)Less than11.137
Return on Equity (MRQ)Greater than0.15-0.003
Return on Assets (MRQ)Greater than0.05-0.002
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Kangmei Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.393
Ma 20Greater thanMa 502.021
Ma 50Greater thanMa 1001.925
Ma 100Greater thanMa 2001.906
OpenGreater thanClose2.090
Total3/5 (60.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-09-302022-12-312023-03-312023-06-302023-09-30
Interest Income  9,66360,09069,754-61,8987,85616,32724,183-65,054-40,871



Latest Balance Sheet

Balance Sheet of 2023-09-30. Currency in CNY. All numbers in thousands.

Summary
Total Assets14,564,851
Total Liabilities7,730,794
Total Stockholder Equity6,800,752
 As reported
Total Liabilities 7,730,794
Total Stockholder Equity+ 6,800,752
Total Assets = 14,564,851

Assets

Total Assets14,564,851
Total Current Assets7,019,562
Long-term Assets7,545,288
Total Current Assets
Cash And Cash Equivalents 1,186,017
Short-term Investments 91
Net Receivables 1,840,912
Inventory 2,813,774
Other Current Assets 200,936
Total Current Assets  (as reported)7,019,562
Total Current Assets  (calculated)6,041,730
+/- 977,832
Long-term Assets
Property Plant Equipment 4,030,174
Goodwill 106,351
Intangible Assets 507,815
Long-term Assets Other 23,062
Long-term Assets  (as reported)7,545,288
Long-term Assets  (calculated)4,667,402
+/- 2,877,887

Liabilities & Shareholders' Equity

Total Current Liabilities5,149,541
Long-term Liabilities2,581,254
Total Stockholder Equity6,800,752
Total Current Liabilities
Short Long Term Debt 33,047
Accounts payable 2,217,878
Other Current Liabilities 155,773
Total Current Liabilities  (as reported)5,149,541
Total Current Liabilities  (calculated)2,406,698
+/- 2,742,843
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt195,859
Long-term Liabilities Other 894,273
Long-term Liabilities  (as reported)2,581,254
Long-term Liabilities  (calculated)1,090,132
+/- 1,491,122
Total Stockholder Equity
Total Stockholder Equity (as reported)6,800,752
Total Stockholder Equity (calculated)0
+/- 6,800,752
Other
Capital Stock13,863,867
Common Stock Shares Outstanding 13,863,867
Net Invested Capital 6,833,798
Net Working Capital 1,870,022
Property Plant and Equipment Gross 4,030,174



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-06-302000-12-31
> Total Assets 
231,229
481,717
517,609
529,642
547,616
526,530
629,579
636,925
669,962
680,018
704,689
780,681
764,923
825,411
853,965
872,316
867,256
848,966
790,042
973,940
1,076,375
1,681,934
1,922,124
1,720,913
2,125,764
3,220,014
3,201,848
3,411,597
3,979,627
3,952,996
4,208,585
4,526,229
5,844,631
5,954,439
6,216,997
6,379,499
7,174,582
7,511,261
8,208,198
12,441,522
14,392,861
14,334,324
15,237,495
16,151,509
16,522,138
16,979,971
17,958,293
19,409,533
19,584,723
19,901,249
22,251,389
24,149,465
24,743,730
23,587,148
27,879,317
31,760,676
32,120,275
33,020,317
38,105,229
39,521,944
47,955,281
53,006,974
54,823,897
58,425,801
59,537,251
65,336,705
68,722,021
72,194,873
81,812,599
74,627,938
73,797,095
72,200,935
71,783,317
65,486,267
64,499,163
62,424,749
61,500,202
36,212,980
36,120,468
35,055,982
31,495,196
16,054,259
15,919,719
15,672,515
15,562,044
15,111,759
14,800,806
14,587,350
14,564,851
14,564,85114,587,35014,800,80615,111,75915,562,04415,672,51515,919,71916,054,25931,495,19635,055,98236,120,46836,212,98061,500,20262,424,74964,499,16365,486,26771,783,31772,200,93573,797,09574,627,93881,812,59972,194,87368,722,02165,336,70559,537,25158,425,80154,823,89753,006,97447,955,28139,521,94438,105,22933,020,31732,120,27531,760,67627,879,31723,587,14824,743,73024,149,46522,251,38919,901,24919,584,72319,409,53317,958,29316,979,97116,522,13816,151,50915,237,49514,334,32414,392,86112,441,5228,208,1987,511,2617,174,5826,379,4996,216,9975,954,4395,844,6314,526,2294,208,5853,952,9963,979,6273,411,5973,201,8483,220,0142,125,7641,720,9131,922,1241,681,9341,076,375973,940790,042848,966867,256872,316853,965825,411764,923780,681704,689680,018669,962636,925629,579526,530547,616529,642517,609481,717231,229
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
59,804,750
65,488,430
54,240,975
53,420,788
51,910,737
51,537,731
47,013,073
48,016,369
46,119,661
45,193,761
21,902,034
21,736,452
21,696,721
18,265,793
8,284,793
8,232,663
8,031,746
8,012,813
7,383,990
7,122,767
6,970,567
7,019,562
7,019,5626,970,5677,122,7677,383,9908,012,8138,031,7468,232,6638,284,79318,265,79321,696,72121,736,45221,902,03445,193,76146,119,66148,016,36947,013,07351,537,73151,910,73753,420,78854,240,97565,488,43059,804,7500000000000000000000000000000000000000000000000000000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36,640,021
37,788,463
1,839,201
1,048,014
478,381
483,393
501,527
476,359
360,698
395,728
552,338
580,783
705,705
632,544
2,418,606
2,187,908
2,049,034
1,990,186
1,507,397
1,291,326
1,278,202
1,186,017
1,186,0171,278,2021,291,3261,507,3971,990,1862,049,0342,187,9082,418,606632,544705,705580,783552,338395,728360,698476,359501,527483,393478,3811,048,0141,839,20137,788,46336,640,0210000000000000000000000000000000000000000000000000000000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
524
1,758
0
0
117
117
100
91
91100117117001,758524000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Net Receivables 
47,254
59,784
61,005
55,734
60,985
58,317
65,852
65,699
65,599
71,167
71,844
73,175
75,057
79,246
80,322
82,948
82,465
80,614
79,775
83,772
86,535
91,825
93,151
92,115
110,174
115,203
110,644
113,208
138,196
146,885
165,361
177,089
224,832
234,317
294,926
294,668
325,626
383,512
504,823
572,048
647,694
772,738
822,502
966,420
1,195,037
1,422,415
1,434,206
1,637,178
1,745,270
1,905,502
1,958,625
2,071,295
2,435,870
2,342,138
2,645,019
2,764,199
3,190,608
2,849,548
3,223,892
3,113,617
3,708,934
3,585,275
3,774,222
3,965,957
4,563,400
4,714,872
5,484,931
5,561,648
6,789,973
16,680,643
6,294,646
5,839,751
5,283,690
14,472,674
14,313,446
13,945,037
13,056,787
12,045,907
11,423,413
11,810,753
11,222,514
2,372,926
2,553,061
2,627,327
2,401,356
1,964,955
1,917,105
2,817,986
1,840,912
1,840,9122,817,9861,917,1051,964,9552,401,3562,627,3272,553,0612,372,92611,222,51411,810,75311,423,41312,045,90713,056,78713,945,03714,313,44614,472,6745,283,6905,839,7516,294,64616,680,6436,789,9735,561,6485,484,9314,714,8724,563,4003,965,9573,774,2223,585,2753,708,9343,113,6173,223,8922,849,5483,190,6082,764,1992,645,0192,342,1382,435,8702,071,2951,958,6251,905,5021,745,2701,637,1781,434,2061,422,4151,195,037966,420822,502772,738647,694572,048504,823383,512325,626294,668294,926234,317224,832177,089165,361146,885138,196113,208110,644115,203110,17492,11593,15191,82586,53583,77279,77580,61482,46582,94880,32279,24675,05773,17571,84471,16765,59965,69965,85258,31760,98555,73461,00559,78447,254
       Other Current Assets 
6,953
7,067
4,027
3,724
3,603
3,561
4,557
4,362
3,974
4,692
10,315
10,518
11,870
39,554
7,696
5,719
6,858
4,209
4,154
5,599
6,707
32,671
200,762
205,860
210,472
219,811
233,102
246,269
48,427
41,799
68,814
69,065
181,679
198,050
171,448
239,811
99,470
207,664
199,253
194,659
240,136
215,505
402,887
489,864
293,350
286,403
414,218
397,101
483,997
510,775
401,164
773,671
495,235
568,447
654,656
959,798
868,872
1,048,568
610,781
792,709
709,555
1,073,420
742,807
1,156,218
1,178,729
1,590,542
1,142,525
2,028,790
2,460,131
1,503,426
1,160,151
976,379
965,183
601,598
1,405,578
686,814
1,061,489
263,614
764,844
267,783
776,764
297,831
347,332
189,755
303,881
120,312
185,963
162,162
200,936
200,936162,162185,963120,312303,881189,755347,332297,831776,764267,783764,844263,6141,061,489686,8141,405,578601,598965,183976,3791,160,1511,503,4262,460,1312,028,7901,142,5251,590,5421,178,7291,156,218742,8071,073,420709,555792,709610,7811,048,568868,872959,798654,656568,447495,235773,671401,164510,775483,997397,101414,218286,403293,350489,864402,887215,505240,136194,659199,253207,66499,470239,811171,448198,050181,67969,06568,81441,79948,427246,269233,102219,811210,472205,860200,76232,6716,7075,5994,1544,2096,8585,7197,69639,55411,87010,51810,3154,6923,9744,3624,5573,5613,6033,7244,0277,0676,953
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,376,307
20,290,198
20,245,586
17,547,768
16,482,794
16,305,088
16,306,441
14,310,946
14,384,016
13,359,261
13,229,403
7,769,466
7,687,055
7,640,769
7,549,231
7,727,769
7,678,039
7,616,783
7,545,288
7,545,2887,616,7837,678,0397,727,7697,549,2317,640,7697,687,0557,769,46613,229,40313,359,26114,384,01614,310,94616,306,44116,305,08816,482,79417,547,76820,245,58620,290,19820,376,3070000000000000000000000000000000000000000000000000000000000000000000000
       Property Plant Equipment 
80,511
128,518
180,800
231,599
270,204
307,040
317,611
315,282
316,085
312,124
339,833
375,659
386,854
387,655
408,534
404,886
482,228
409,421
530,952
426,107
583,157
543,011
711,460
627,029
797,238
709,909
992,139
1,068,863
1,576,889
1,098,729
1,792,576
1,275,930
1,859,971
1,388,893
2,483,602
1,605,891
2,581,093
1,689,828
3,141,891
1,898,224
3,343,781
2,621,110
5,297,474
4,053,610
6,512,359
4,774,450
5,890,655
4,173,985
6,031,257
4,306,763
6,377,929
5,002,341
5,179,633
5,161,894
4,764,623
4,778,765
4,801,094
4,817,099
4,963,510
5,002,152
5,851,892
5,923,158
6,161,480
6,229,061
6,218,496
6,171,140
7,190,737
7,367,445
10,822,686
11,937,471
11,997,045
11,931,106
11,858,724
11,409,350
9,955,354
10,898,648
10,897,317
9,139,949
9,261,688
8,548,285
8,456,272
4,642,107
4,591,042
4,571,848
4,506,419
4,179,537
4,111,097
4,072,946
4,030,174
4,030,1744,072,9464,111,0974,179,5374,506,4194,571,8484,591,0424,642,1078,456,2728,548,2859,261,6889,139,94910,897,31710,898,6489,955,35411,409,35011,858,72411,931,10611,997,04511,937,47110,822,6867,367,4457,190,7376,171,1406,218,4966,229,0616,161,4805,923,1585,851,8925,002,1524,963,5104,817,0994,801,0944,778,7654,764,6235,161,8945,179,6335,002,3416,377,9294,306,7636,031,2574,173,9855,890,6554,774,4506,512,3594,053,6105,297,4742,621,1103,343,7811,898,2243,141,8911,689,8282,581,0931,605,8912,483,6021,388,8931,859,9711,275,9301,792,5761,098,7291,576,8891,068,863992,139709,909797,238627,029711,460543,011583,157426,107530,952409,421482,228404,886408,534387,655386,854375,659339,833312,124316,085315,282317,611307,040270,204231,599180,800128,51880,511
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
172,941
223,910
223,910
223,590
240,394
304,735
304,735
304,735
304,735
304,735
316,728
456,186
471,130
471,130
474,051
552,728
552,728
563,921
568,846
568,846
561,124
561,124
116,702
116,702
81,197
81,197
36,909
36,909
36,909
36,909
106,351
106,351
106,351
106,351
106,351
106,351
106,351
106,351
106,351106,351106,351106,351106,351106,351106,351106,35136,90936,90936,90936,90981,19781,197116,702116,702561,124561,124568,846568,846563,921552,728552,728474,051471,130471,130456,186316,728304,735304,735304,735304,735304,735240,394223,590223,910223,910172,941000000000000000000000000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
534,479
551,560
556,577
594,597
611,783
640,632
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000640,632611,783594,597556,577551,560534,4790000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
25,190
23,723
22,257
21,524
20,791
20,057
63,935
62,978
62,263
61,547
60,832
64,809
64,070
63,331
128,014
126,633
72,990
124,382
16,990
122,080
67,475
65,831
72,230
123,039
824
120,690
1,693
297,336
631
485,435
72
512,393
93
554,757
147
938,464
9,348
1,060,303
11,235
1,511,040
11,335
2,129,913
10,739
2,208,913
15,093
2,242,329
42,323
2,037,841
40,267
2,048,801
41,049
1,967,090
2,033,124
2,025,137
1,295,559
1,306,555
1,371,328
1,366,330
1,357,112
1,352,252
1,347,016
1,360,705
2,271,129
2,279,520
2,336,476
2,402,262
2,516,283
1,966,885
2,053,302
2,097,530
2,155,370
193,260
2,138,097
2,021,304
1,340,011
1,334,832
1,322,600
1,308,504
1,297,520
1,042,986
1,032,481
579,730
574,418
569,102
563,731
529,795
518,207
513,001
507,815
507,815513,001518,207529,795563,731569,102574,418579,7301,032,4811,042,9861,297,5201,308,5041,322,6001,334,8321,340,0112,021,3042,138,097193,2602,155,3702,097,5302,053,3021,966,8852,516,2832,402,2622,336,4762,279,5202,271,1291,360,7051,347,0161,352,2521,357,1121,366,3301,371,3281,306,5551,295,5592,025,1372,033,1241,967,09041,0492,048,80140,2672,037,84142,3232,242,32915,0932,208,91310,7392,129,91311,3351,511,04011,2351,060,3039,348938,464147554,75793512,39372485,435631297,3361,693120,690824123,03972,23065,83167,475122,08016,990124,38272,990126,633128,01463,33164,07064,80960,83261,54762,26362,97863,93520,05720,79121,52422,25723,72325,190
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
318,457
305,441
318,886
846,148
820,241
29,364
49,533
91,435
85,090
88,647
83,051
26,344
25,895
25,230
25,617
14,652
14,412
19,128
23,062
23,06219,12814,41214,65225,61725,23025,89526,34483,05188,64785,09091,43549,53329,364820,241846,148318,886305,441318,4570000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
127,266
145,727
152,509
156,478
156,433
124,934
238,346
235,790
253,187
253,446
262,252
326,946
292,099
333,299
342,089
345,413
336,287
299,510
216,449
382,866
458,311
551,286
766,296
548,698
525,211
947,201
882,708
1,037,657
1,323,435
1,241,558
1,292,471
1,501,041
1,867,022
1,875,868
1,945,142
1,938,433
2,663,316
2,828,451
3,282,478
3,842,713
5,707,064
5,449,115
5,989,214
6,497,415
6,672,260
6,832,965
7,375,155
8,252,864
8,494,048
8,363,500
10,221,001
11,530,183
12,262,102
10,625,601
11,160,588
14,214,991
14,653,799
14,900,706
19,266,789
19,717,655
20,222,616
24,436,488
25,440,770
28,184,304
29,436,836
34,189,129
36,587,047
38,593,679
47,095,330
46,327,912
45,274,925
44,124,161
43,756,627
43,577,336
42,887,764
43,174,941
43,200,630
43,272,141
43,776,507
43,037,408
42,902,488
6,085,785
6,062,801
5,899,549
6,487,608
8,129,210
7,870,474
7,729,260
7,730,794
7,730,7947,729,2607,870,4748,129,2106,487,6085,899,5496,062,8016,085,78542,902,48843,037,40843,776,50743,272,14143,200,63043,174,94142,887,76443,577,33643,756,62744,124,16145,274,92546,327,91247,095,33038,593,67936,587,04734,189,12929,436,83628,184,30425,440,77024,436,48820,222,61619,717,65519,266,78914,900,70614,653,79914,214,99111,160,58810,625,60112,262,10211,530,18310,221,0018,363,5008,494,0488,252,8647,375,1556,832,9656,672,2606,497,4155,989,2145,449,1155,707,0643,842,7133,282,4782,828,4512,663,3161,938,4331,945,1421,875,8681,867,0221,501,0411,292,4711,241,5581,323,4351,037,657882,708947,201525,211548,698766,296551,286458,311382,866216,449299,510336,287345,413342,089333,299292,099326,946262,252253,446253,187235,790238,346124,934156,433156,478152,509145,727127,266
   > Total Current Liabilities 
91,266
90,022
152,509
156,478
156,433
124,934
188,346
185,490
203,003
202,446
261,452
281,448
247,099
248,299
257,089
260,013
250,887
292,110
216,449
380,866
457,511
550,486
766,296
545,898
507,411
929,401
874,063
1,016,012
625,931
533,453
654,508
852,096
1,158,136
1,055,399
1,117,291
699,599
1,406,999
1,456,152
1,632,640
1,934,336
1,585,885
1,271,307
2,049,883
2,543,152
2,894,387
3,223,490
3,750,144
4,614,449
4,586,896
5,293,582
7,133,332
8,423,995
9,354,984
7,718,736
8,248,009
8,906,700
9,347,073
9,590,946
13,879,178
14,334,830
14,833,583
19,027,314
20,024,441
22,765,915
26,509,424
25,247,401
25,607,574
25,604,855
29,404,925
26,036,494
24,977,900
23,820,288
23,449,541
27,823,065
11,652,679
20,138,387
20,149,818
22,822,069
23,164,535
27,274,022
27,131,727
4,946,572
4,918,072
4,743,632
5,448,051
5,441,512
5,157,359
5,023,285
5,149,541
5,149,5415,023,2855,157,3595,441,5125,448,0514,743,6324,918,0724,946,57227,131,72727,274,02223,164,53522,822,06920,149,81820,138,38711,652,67927,823,06523,449,54123,820,28824,977,90026,036,49429,404,92525,604,85525,607,57425,247,40126,509,42422,765,91520,024,44119,027,31414,833,58314,334,83013,879,1789,590,9469,347,0738,906,7008,248,0097,718,7369,354,9848,423,9957,133,3325,293,5824,586,8964,614,4493,750,1443,223,4902,894,3872,543,1522,049,8831,271,3071,585,8851,934,3361,632,6401,456,1521,406,999699,5991,117,2911,055,3991,158,136852,096654,508533,453625,9311,016,012874,063929,401507,411545,898766,296550,486457,511380,866216,449292,110250,887260,013257,089248,299247,099281,448261,452202,446203,003185,490188,346124,934156,433156,478152,50990,02291,266
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500,000
0
0
14,940,000
15,230,000
15,851,682
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000015,851,68215,230,00014,940,000002,500,0000000000000000000000000000000000000000000000000000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500,000
0
0
14,940,000
15,230,000
15,851,682
12,756,638
3,398,728
2,891,635
2,890,031
2,314,767
2,312,743
1,490,346
1,488,852
15,174
17,908
18,319
26,448
25,619
26,009
11,716
33,047
33,04711,71626,00925,61926,44818,31917,90815,1741,488,8521,490,3462,312,7432,314,7672,890,0312,891,6353,398,72812,756,63815,851,68215,230,00014,940,000002,500,0000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
32,370
21,046
35,306
37,166
37,611
36,584
38,575
34,708
37,849
36,448
37,593
31,446
36,343
39,354
41,856
43,233
44,106
46,218
47,106
41,242
43,167
41,092
46,308
47,974
58,627
53,553
62,647
64,730
70,797
80,378
85,559
79,276
131,835
132,380
174,795
157,955
192,894
194,698
269,196
278,702
291,340
363,304
453,067
456,098
552,657
687,532
763,986
932,654
875,667
952,367
975,884
1,372,462
1,455,772
1,025,647
1,790,898
1,996,393
2,133,494
1,930,289
1,645,623
1,654,032
1,694,663
1,782,015
1,756,811
2,080,011
2,339,136
2,450,293
2,103,595
2,204,374
2,793,942
3,160,462
3,319,352
3,459,616
3,133,793
3,773,896
3,383,184
3,677,187
3,615,982
3,296,146
3,170,898
3,087,776
2,998,788
2,015,050
2,021,746
1,966,524
2,058,760
2,563,450
2,251,780
2,115,061
2,217,878
2,217,8782,115,0612,251,7802,563,4502,058,7601,966,5242,021,7462,015,0502,998,7883,087,7763,170,8983,296,1463,615,9823,677,1873,383,1843,773,8963,133,7933,459,6163,319,3523,160,4622,793,9422,204,3742,103,5952,450,2932,339,1362,080,0111,756,8111,782,0151,694,6631,654,0321,645,6231,930,2892,133,4941,996,3931,790,8981,025,6471,455,7721,372,462975,884952,367875,667932,654763,986687,532552,657456,098453,067363,304291,340278,702269,196194,698192,894157,955174,795132,380131,83579,27685,55980,37870,79764,73062,64753,55358,62747,97446,30841,09243,16741,24247,10646,21844,10643,23341,85639,35436,34331,44637,59336,44837,84934,70838,57536,58437,61137,16635,30621,04632,370
       Other Current Liabilities 
18,896
8,976
23,203
25,312
24,822
11,350
27,771
28,782
13,154
13,998
13,859
10,002
15,756
13,945
15,233
16,780
16,781
15,892
14,343
209,624
214,344
220,394
21,068
28,924
29,784
426,848
432,416
432,282
36,134
34,075
0
13,820
52,057
48,775
82,252
76,400
103,861
101,210
123,444
175,634
144,545
108,003
256,816
447,054
537,730
631,958
686,158
787,719
1,117,153
1,785,917
2,988,483
1,641,495
2,679,212
2,273,089
1,837,111
2,010,307
1,995,226
2,040,852
2,109,055
2,056,125
2,034,846
2,450,799
2,515,291
2,958,476
3,097,864
6,231,563
4,633,732
3,613,795
3,796,939
3,245,812
2,750,000
750,000
3,800,396
5,189,883
3,838,273
5,234,899
5,945,737
5,792,519
6,252,663
5,734,548
6,199,351
1,745,666
2,654,308
1,625,038
3,146,509
144,606
148,628
1,692,034
155,773
155,7731,692,034148,628144,6063,146,5091,625,0382,654,3081,745,6666,199,3515,734,5486,252,6635,792,5195,945,7375,234,8993,838,2735,189,8833,800,396750,0002,750,0003,245,8123,796,9393,613,7954,633,7326,231,5633,097,8642,958,4762,515,2912,450,7992,034,8462,056,1252,109,0552,040,8521,995,2262,010,3071,837,1112,273,0892,679,2121,641,4952,988,4831,785,9171,117,153787,719686,158631,958537,730447,054256,816108,003144,545175,634123,444101,210103,86176,40082,25248,77552,05713,820034,07536,134432,282432,416426,84829,78428,92421,068220,394214,344209,62414,34315,89216,78116,78015,23313,94515,75610,00213,85913,99813,15428,78227,77111,35024,82225,31223,2038,97618,896
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,297,025
20,303,873
20,307,086
21,387,666
31,235,085
23,036,555
23,050,811
20,450,072
20,611,972
15,763,387
15,770,761
1,139,213
1,144,730
1,155,917
1,039,557
2,687,699
2,713,114
2,705,975
2,581,254
2,581,2542,705,9752,713,1142,687,6991,039,5571,155,9171,144,7301,139,21315,770,76115,763,38720,611,97220,450,07223,050,81123,036,55531,235,08521,387,66620,307,08620,303,87320,297,0250000000000000000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2,500,000
0
0
-14,940,000
-15,230,000
-15,851,682
0
0
0
0
0
166,031
153,347
168,863
153,220
168,147
196,198
188,980
199,130
189,630
199,677
195,859
195,859199,677189,630199,130188,980196,198168,147153,220168,863153,347166,03100000-15,851,682-15,230,000-14,940,00000-2,500,0000000000000000000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
17,473,010
17,482,605
17,492,201
500,000
500,000
21,966,373
679
0
659
0
659
0
293,021
0
0
980,631
979,811
970,781
894,273
894,273970,781979,811980,63100293,02106590659067921,966,373500,000500,00017,492,20117,482,60517,473,0100000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
256,720
274,442
280,413
302,541
296,004
304,941
244,229
279,999
229,006
214,762
119,345
104,122
106,838
91,298
110,222
103,648
97,255
90,773
0
0
0
0
000090,77397,255103,648110,22291,298106,838104,122119,345214,762229,006279,999244,229304,941296,004302,541280,413274,442256,7200000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
103,963
335,991
365,100
373,164
391,183
401,596
391,232
401,135
416,775
426,572
442,436
453,736
472,824
492,112
511,877
526,903
530,968
549,456
573,593
591,074
618,065
1,130,649
1,155,827
1,172,215
1,600,553
2,272,813
2,319,140
2,373,940
2,656,192
2,711,437
2,916,115
3,025,188
3,977,609
4,078,571
4,271,855
4,441,066
4,511,266
4,682,810
4,925,719
8,598,809
8,684,010
8,883,459
9,246,294
9,652,155
9,848,087
10,145,268
10,580,984
11,140,957
11,088,518
11,535,574
12,027,637
12,616,635
12,478,992
12,959,043
16,715,965
17,543,088
17,445,002
18,097,148
18,765,127
19,734,299
27,664,784
28,503,825
29,115,570
30,145,726
30,009,425
31,053,016
32,032,960
30,533,360
31,652,351
25,227,250
28,415,731
27,976,571
27,924,084
21,810,118
21,513,843
19,109,017
18,161,070
-7,185,810
-7,780,988
-8,115,361
-11,541,830
9,926,555
9,815,133
9,730,912
9,032,649
6,947,131
6,897,854
6,825,462
6,800,752
6,800,7526,825,4626,897,8546,947,1319,032,6499,730,9129,815,1339,926,555-11,541,830-8,115,361-7,780,988-7,185,81018,161,07019,109,01721,513,84321,810,11827,924,08427,976,57128,415,73125,227,25031,652,35130,533,36032,032,96031,053,01630,009,42530,145,72629,115,57028,503,82527,664,78419,734,29918,765,12718,097,14817,445,00217,543,08816,715,96512,959,04312,478,99212,616,63512,027,63711,535,57411,088,51811,140,95710,580,98410,145,2689,848,0879,652,1559,246,2948,883,4598,684,0108,598,8094,925,7194,682,8104,511,2664,441,0664,271,8554,078,5713,977,6093,025,1882,916,1152,711,4372,656,1922,373,9402,319,1402,272,8131,600,5531,172,2151,155,8271,130,649618,065591,074573,593549,456530,968526,903511,877492,112472,824453,736442,436426,572416,775401,135391,232401,596391,183373,164365,100335,991103,963
   Common Stock
52,800
70,800
70,800
70,800
70,800
70,800
70,800
70,800
70,800
70,800
70,800
70,800
106,200
106,200
106,200
106,200
106,200
106,200
106,200
106,200
159,300
219,300
219,300
219,300
438,600
509,600
509,600
764,400
764,400
764,400
764,400
764,400
1,694,370
1,694,370
1,694,370
1,694,370
1,694,370
1,694,370
1,694,370
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,714
2,198,715
2,198,715
2,198,715
2,198,715
2,198,715
4,397,429
4,397,429
4,397,429
4,397,429
4,947,224
4,947,224
4,947,224
4,947,224
4,946,744
4,946,744
4,974,254
4,974,254
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
4,973,862
13,863,867
13,863,867
13,863,867
13,863,867
0
0
0
0
000013,863,86713,863,86713,863,86713,863,8674,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,973,8624,974,2544,974,2544,946,7444,946,7444,947,2244,947,2244,947,2244,947,2244,397,4294,397,4294,397,4294,397,4292,198,7152,198,7152,198,7152,198,7152,198,7152,198,7142,198,7142,198,7142,198,7142,198,7142,198,7142,198,7142,198,7142,198,7142,198,7142,198,7142,198,7141,694,3701,694,3701,694,3701,694,3701,694,3701,694,3701,694,370764,400764,400764,400764,400764,400509,600509,600438,600219,300219,300219,300159,300106,200106,200106,200106,200106,200106,200106,200106,20070,80070,80070,80070,80070,80070,80070,80070,80070,80070,80070,80052,800
   Retained Earnings 
41,365
56,924
51,988
60,052
78,072
88,484
71,546
81,448
97,088
106,885
115,069
125,569
138,377
157,665
166,748
181,775
185,839
204,327
212,567
227,393
235,799
263,383
270,897
294,719
269,580
306,297
337,961
341,801
408,287
463,532
575,277
684,351
367,116
468,078
599,226
768,437
849,119
1,011,454
1,187,235
1,426,540
1,513,008
1,718,118
1,983,133
2,387,687
2,581,152
2,879,572
3,175,865
3,733,751
3,680,640
4,123,060
4,433,547
5,670,206
5,534,186
6,005,679
6,793,363
7,611,441
6,405,818
7,080,410
7,729,652
8,718,691
8,431,430
9,257,137
10,005,803
11,015,000
10,859,012
11,858,805
12,867,738
14,290,823
15,321,176
8,989,453
7,599,010
7,119,259
7,066,933
1,367,805
2,332,152
-56,037
-1,003,729
-26,356,135
-26,951,366
-27,285,669
-30,712,047
-21,790,482
-21,901,904
-21,986,128
-22,676,252
-26,004,732
-26,053,817
-26,129,266
-26,151,417
-26,151,417-26,129,266-26,053,817-26,004,732-22,676,252-21,986,128-21,901,904-21,790,482-30,712,047-27,285,669-26,951,366-26,356,135-1,003,729-56,0372,332,1521,367,8057,066,9337,119,2597,599,0108,989,45315,321,17614,290,82312,867,73811,858,80510,859,01211,015,00010,005,8039,257,1378,431,4308,718,6917,729,6527,080,4106,405,8187,611,4416,793,3636,005,6795,534,1865,670,2064,433,5474,123,0603,680,6403,733,7513,175,8652,879,5722,581,1522,387,6871,983,1331,718,1181,513,0081,426,5401,187,2351,011,454849,119768,437599,226468,078367,116684,351575,277463,532408,287341,801337,961306,297269,580294,719270,897263,383235,799227,393212,567204,327185,839181,775166,748157,665138,377125,569115,069106,88597,08881,44871,54688,48478,07260,05251,98856,92441,365
   Capital Surplus 00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000000000000000-383,211-385,986-385,986-95,205-136,007-139,405-139,40500000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-6,635
-13,627
-2,790
-2,437
-1,652
-1,813
-3,505
-165
-3,244
-3,409
-3,737
-3,597
-3,579
-3,583
3,101
3,101
3,104
3,101
0
0
1,322
0
01,322003,1013,1043,1013,101-3,583-3,579-3,597-3,737-3,409-3,244-165-3,505-1,813-1,652-2,437-2,790-13,627-6,6350000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue4,992,464
Cost of Revenue-4,223,703
Gross Profit768,761768,761
 
Operating Income (+$)
Gross Profit768,761
Operating Expense-5,966,734
Operating Income-974,270-5,197,974
 
Operating Expense (+$)
Research Development43,963
Selling General Administrative711,555
Selling And Marketing Expenses-
Operating Expense5,966,734755,518
 
Net Interest Income (+$)
Interest Income45,209
Interest Expense-80,380
Other Finance Cost-12,160
Net Interest Income-47,330
 
Pretax Income (+$)
Operating Income-974,270
Net Interest Income-47,330
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,919,869-974,270
EBIT - interestExpense = -80,380
-1,950,913
-1,870,533
Interest Expense80,380
Earnings Before Interest and Taxes (EBIT)--1,839,489
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,919,869
Tax Provision-35,942
Net Income From Continuing Ops-1,955,811-1,955,811
Net Income-1,950,913
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-47,330
 

Technical Analysis of Kangmei
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kangmei. The general trend of Kangmei is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kangmei's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Kangmei Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.28 < 2.4 < 2.42.

The bearish price targets are: 2.04 > 2.03 > 2.02.

Tweet this
Kangmei Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Kangmei Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Kangmei Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Kangmei Pharmaceutical Co Ltd. The current macd is 0.07152789.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kangmei price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Kangmei. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Kangmei price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Kangmei Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartKangmei Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Kangmei Pharmaceutical Co Ltd. The current adx is 36.18.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Kangmei shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Kangmei Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Kangmei Pharmaceutical Co Ltd. The current sar is 2.314192.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Kangmei Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Kangmei Pharmaceutical Co Ltd. The current rsi is 65.39. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Kangmei Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartKangmei Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Kangmei Pharmaceutical Co Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kangmei price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Kangmei Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartKangmei Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Kangmei Pharmaceutical Co Ltd. The current cci is 79.87.

Kangmei Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartKangmei Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Kangmei Pharmaceutical Co Ltd. The current cmo is 30.91.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Kangmei Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartKangmei Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Kangmei Pharmaceutical Co Ltd. The current willr is -37.20930233.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Kangmei is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Kangmei Pharmaceutical Co Ltd Daily Williams %R ChartKangmei Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Kangmei Pharmaceutical Co Ltd.

Kangmei Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Kangmei Pharmaceutical Co Ltd. The current atr is 0.07443034.

Kangmei Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartKangmei Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Kangmei Pharmaceutical Co Ltd. The current obv is 24,866,987.

Kangmei Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartKangmei Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Kangmei Pharmaceutical Co Ltd. The current mfi is 71.49.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Kangmei Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartKangmei Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Kangmei Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-29ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-26RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-27SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Kangmei Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Kangmei Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5065.393
Ma 20Greater thanMa 502.021
Ma 50Greater thanMa 1001.925
Ma 100Greater thanMa 2001.906
OpenGreater thanClose2.090
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kangmei with someone you think should read this too:
  • Are you bullish or bearish on Kangmei? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kangmei? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Kangmei Pharmaceutical Co Ltd

I send you an email if I find something interesting about Kangmei Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Kangmei Pharmaceutical Co Ltd.

Receive notifications about Kangmei Pharmaceutical Co Ltd in your mailbox!